Biomind Labs Inc.
BMND
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 100.90K | 106.30K | 108.40K | 43.60K | 89.20K |
| Depreciation & Amortization | 2.20K | 2.20K | 2.20K | 0.00 | 2.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 90.90K | 108.50K | 110.70K | 92.40K | 128.60K |
| Operating Income | -90.90K | -108.50K | -110.70K | -92.40K | -128.60K |
| Income Before Tax | -34.50K | -212.10K | -186.20K | -272.10K | -125.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -34.50K | -212.10K | -186.20K | -272.10K | -125.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -34.50K | -212.10K | -186.20K | -272.10K | -125.60K |
| EBIT | -90.90K | -108.50K | -110.70K | -92.40K | -128.60K |
| EBITDA | -88.60K | -106.30K | -108.40K | -90.70K | -117.90K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 77.47M | 74.76M | 74.76M | 74.76M | 74.76M |
| Average Diluted Shares Outstanding | 77.47M | 74.76M | 74.76M | 74.76M | 74.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |